Diagnostic company’s shares are down 90% since its rapid antigen tests were the first to be approved for Covid-19
Diagnostic company QuidelOrtho is reportedly exploring the sale of one of its testing units. This move comes as private equity firms show increased interest in healthcare companies. The company's shares have plummeted 90% since its rapid antigen tests were among the first…
Market Samachar is a news aggregator. This article was originally published by International homepage. Tap the button above to read the full story on their site.